ArticleCureus2023

A Comparative Study of Ischemia-Modified Albumin: A Promising Biomarker for Early Detection of Acute Coronary Syndrome (ACS).

Pranav Jawade et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.